Winner Medical Co., Ltd. (300888.SZ)
CNY 40.96
(0.1%)
CNY 40.96
(0.1%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 8.18 Billion CNY | -28.48% |
| 2022 | 11.35 Billion CNY | 41.23% |
| 2021 | 8.03 Billion CNY | -35.87% |
| 2020 | 12.53 Billion CNY | 173.99% |
| 2019 | 4.57 Billion CNY | 19.16% |
| 2018 | 3.83 Billion CNY | 9.76% |
| 2017 | 3.49 Billion CNY | 36.63% |
| 2016 | 2.55 Billion CNY | 40.72% |
| 2015 | 1.81 Billion CNY | 20.48% |
| 2014 | 1.5 Billion CNY | 18.7% |
| 2013 | 1.27 Billion CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 1.89 Billion CNY | -12.3% |
| 2024 Q3 | 2.02 Billion CNY | -3.21% |
| 2024 Q2 | 2.1 Billion CNY | 11.17% |
| 2023 Q1 | 2.35 Billion CNY | -36.58% |
| 2023 Q4 | 2.15 Billion CNY | 23.78% |
| 2023 FY | 8.11 Billion CNY | -28.48% |
| 2023 Q3 | 1.74 Billion CNY | -8.94% |
| 2023 Q2 | 1.91 Billion CNY | -18.6% |
| 2022 Q4 | 3.7 Billion CNY | 49.29% |
| 2022 Q3 | 2.48 Billion CNY | -12.39% |
| 2022 Q2 | 2.83 Billion CNY | 22.1% |
| 2022 Q1 | 2.32 Billion CNY | 4.73% |
| 2022 FY | 11.35 Billion CNY | 41.23% |
| 2021 FY | 8.03 Billion CNY | -35.87% |
| 2021 Q3 | 1.76 Billion CNY | -1.74% |
| 2021 Q4 | 2.21 Billion CNY | 25.99% |
| 2021 Q1 | 2.26 Billion CNY | -24.65% |
| 2021 Q2 | 1.79 Billion CNY | -21.04% |
| 2020 Q2 | 2.69 Billion CNY | 81.85% |
| 2020 FY | 12.53 Billion CNY | 173.99% |
| 2020 Q1 | 1.48 Billion CNY | 1.86% |
| 2020 Q3 | 5.34 Billion CNY | 98.14% |
| 2020 Q4 | 3.01 Billion CNY | -43.65% |
| 2019 Q4 | 1.45 Billion CNY | 43.7% |
| 2019 FY | 4.57 Billion CNY | 19.16% |
| 2019 Q3 | 1.01 Billion CNY | -3.75% |
| 2019 Q2 | 1.05 Billion CNY | 0.0% |
| 2019 Q1 | 1.05 Billion CNY | 0.0% |
| 2018 FY | 3.83 Billion CNY | 9.76% |
| 2017 FY | 3.49 Billion CNY | 36.63% |
| 2016 FY | 2.55 Billion CNY | 40.72% |
| 2015 FY | 1.81 Billion CNY | 20.48% |
| 2014 FY | 1.5 Billion CNY | 18.7% |
| 2013 FY | 1.27 Billion CNY | 0.0% |